TASI 8150 · Insurance · ACIG
Statement of Changes in Equity
FY 2023Equity movements
| Movement | TotalSAR thousands |
|---|---|
| STATEMENT OF CHANGES IN EQUITY | |
| Balance as at 1 January 2023, as previously reported | 162,311 |
| Transition adjustment on initial application of IFRS 17, net of Zakat and tax | (11,095) |
| Transition adjustment on initial application of IFRS 09, net of Zakat and tax | 37,731 |
| Restated balance as at 1 January 2023 | 188,947 |
| Sale of investments measured at fair value through OCI | - |
| Net change in fair value of FVOCI Investments | 3,760 |
| Actuarial losses on employees’ terminal benefits | (1,770) |
| Net Profit for the year attributable to the shareholders | 63,406 |
| Total comprehensive (loss) / income for the year | 65,396 |
| Balance as at 31 December 2023 | 254,343 |
| Balance as at 01 January 2022, as previously reported | 32,036 |
| Transition adjustment on initial application of IFRS 17, net of Zakat and tax - 2022 | (6,856) |
| Transition adjustment on initial application of IFRS 09, net of Zakat and tax - 2022 | 34,862 |
| Restated balance as at 1 January 2022 | 60,042 |
| Net change in fair value of FVOCI Investments (Restated) | 20 |
| Right issue expenses | (2,876) |
| Actuarial losses on employees’ terminal benefits - 2022 | (895) |
| Net loss for the year attributable to the shareholders (Restated) | (17,344) |
| Total comprehensive (loss) / income for the year - 2022 | (21,095) |
| Increase in share capital through right issue | 150,000 |
| Balance as at 31 December 2022 (Restated) | 188,947 |